- 50+ clinical sites in Poland, Bulgaria, Romania, Germany
- 50+ investigators in dermatology
- Therapeutic equivalence trials
- Adhesion studies
- Pharmacokinetic trials
Psoriasis
- phase 3 trial in 480 patients
Dermatomycosis
- phase III trial in 260 patients
Herpes simplex infection
- two phase III trials in over 200 patients